Ingevity Corp (NASDAQ:NGVT) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $46.57 and last traded at $46.11, with a volume of 434,056 shares traded. The stock had previously closed at $44.45.

Several equities research analysts recently issued reports on NGVT shares. Oppenheimer Holdings started coverage on shares of Ingevity Corp in a report on Tuesday, May 31st. They issued an “outperform” rating and a $33.00 target price on the stock. BB&T Corp. started coverage on shares of Ingevity Corp in a report on Friday, June 10th. They issued a “buy” rating and a $44.00 target price on the stock. Zacks Investment Research upgraded shares of Ingevity Corp from a “hold” rating to a “buy” rating and set a $49.00 target price on the stock in a report on Tuesday, August 9th. KeyCorp started coverage on shares of Ingevity Corp in a report on Thursday, July 7th. They issued an “overweight” rating and a $43.00 target price on the stock. Finally, SunTrust Banks restated a “buy” rating on shares of Ingevity Corp in a report on Saturday, August 6th. Five analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and an average price target of $42.25.

The firm has a 50-day moving average of $41.69 and a 200 day moving average of $36.76.

Ingevity Corp (NASDAQ:NGVT) last announced its quarterly earnings results on Wednesday, August 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.15. Equities research analysts forecast that Ingevity Corp will post $1.92 earnings per share for the current year.

Ingevity Corporation is a manufacturer of specialty chemicals, carbon materials and technologies. The Company operates through two segments: Performance Materials and Performance Chemicals. The Company’s specialty chemicals products serve as inputs used in a range of high performance applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants and printing inks.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.